1. Home
  2. EVTC vs NVAX Comparison

EVTC vs NVAX Comparison

Compare EVTC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$25.68

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

NVAX

Novavax Inc.

HOLD

Current Price

$11.27

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTC
NVAX
Founded
1988
1987
Country
United States
United States
Employees
N/A
1992
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
EVTC
NVAX
Price
$25.68
$11.27
Analyst Decision
Hold
Hold
Analyst Count
5
9
Target Price
$35.80
$10.78
AVG Volume (30 Days)
456.6K
3.4M
Earning Date
01-01-0001
05-20-2026
Dividend Yield
0.79%
N/A
EPS Growth
42.98
309.76
EPS
1.64
2.58
Revenue
$453,869,000.00
$1,123,479,000.00
Revenue This Year
$11.45
$58.91
Revenue Next Year
$5.64
N/A
P/E Ratio
$15.43
$3.77
Revenue Growth
11.48
64.69
52 Week Low
$24.95
$5.01
52 Week High
$38.56
$10.63

Technical Indicators

Market Signals
Indicator
EVTC
NVAX
Relative Strength Index (RSI) 36.04 74.43
Support Level N/A $6.34
Resistance Level $30.35 N/A
Average True Range (ATR) 0.85 0.63
MACD -0.12 0.16
Stochastic Oscillator 25.82 85.13

Price Performance

Historical Comparison
EVTC
NVAX

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: